Inventor
Taeyoung Yoon
Inventor
Guilford, CT, US
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds43%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes13%
C07CAcyclic or carbocyclic compounds4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
LOC234%
C04BLime, magnesia2%
PatentTitleYear
10,125,118Heteroaryl compounds and their use as therapeutic drugs20189,834,550Pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (KDMs)2017D0789484'Water ionizer'2017D0788877'Water ionizer'20178,338,591'3-aryl-5,6-disubstituted pyridazines'20128,222,248'Organic compounds'20127,566,712'Biaryl piperazinyl-pyridine analogues'20097,304,059'Substituted quinazolin-4-ylamine analogues'20077,241,765'Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues'20077,223,778'5-substituted-2-arylpyridines'20077,202,250'Substituted arylpyrazines'20077,179,807'5-substituted-2-arylpyrazines'20077,148,225'Substituted biaryl amides as C5A receptor modulators'20066,995,161'Substituted arylpyrazines'20066,953,801'Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues'20056,858,637'Substituted biaryl amides as C5a receptor modulators'20056,583,169'N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives'20036,495,686'Pyrimido 4,5,bindolizine derivatives and aza analogues thereof; CRF1 specific ligands'20026,440,969'Certain isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligands'20026,353,103'Isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligands'20026,281,237'N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives'20016,235,752'Isoquinolinamine and phthalazinamine derivatives which interact with CRF receptors'20016,194,574'Pyrido[2,3-b]indolizine derivatives and aza analogues thereof: CRF1 specific ligands'20016,114,530'Isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF.sub.1 specific ligands'20006,020,341'Enediyne quinone imines and methods of preparation and use thereof'20005,622,958'Enediyne quinone imines and methods of preparation and use thereof'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2000Patents assigned to SLOAN KETTERING INST CANCER (2)· patent assignee history
2000–2009Patents assigned to NEUROGEN CORP (18)· patent assignee history
2000–2002Based in East Haven, CT, US· patent location history
2001–2009Based in Guilford, CT, US· patent location history
2007–2012Based in Newton, MA, US· patent location history
2012Patents assigned to YOON TAEYOUNG (2)· patent assignee history
2012Patents assigned to COPPOLA GARY MARK (1)· patent assignee history
2017Patents assigned to TAEYOUNG E&T CO LTD (2)· patent assignee history
2017–2018Based in Seoul, KR· patent location history
2017Based in Busan, KR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NEUROGEN CORP | 18 | 2000–2009 |
| SLOAN KETTERING INST CANCER | 2 | 1997–2000 |
| TAEYOUNG E&T CO LTD | 2 | 2017 |
| YOON TAEYOUNGself | 2 | 2012 |
| COPPOLA GARY MARK | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Guilford, CT, US | 12 | 2001–2009 |
| Newton, Massachusetts, US | 4 | 2007–2012 |
| East Haven, CT, US | 4 | 2000–2002 |
| Seoul, KR | 2 | 2017–2018 |
| Busan, KR | 2 | 2017 |